SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-13-002469
Filing Date
2013-07-03
Accepted
2013-07-03 17:11:01
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT admp-10k_033113.htm 10-K 1484493
2 CERTIFICATE OF AMENDMENT ex3-3.htm EX-3.3 9809
3 SUBSIDIARIES OF THE REGISTRANT ex-21.htm EX-21 5513
4 CONSENT ex23_1.htm EX-23.1 7552
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-31_1.htm EX-31.1 17772
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-31_2.htm EX-31.2 18053
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex-32_1.htm EX-32.1 7769
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex-32_2.htm EX-32.2 7652
  Complete submission text file 0001387131-13-002469.txt   9266958

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT admp-20130331.xml EX-101.INS 798170
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20130331.xsd EX-101.SCH 57841
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20130331_cal.xml EX-101.CAL 50589
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20130331_def.xml EX-101.DEF 155997
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20130331_lab.xml EX-101.LAB 372090
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20130331_pre.xml EX-101.PRE 256142
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-26372 | Film No.: 13953989
SIC: 2834 Pharmaceutical Preparations